Inhibition of methotrexate induced toxicity in the adult rat spleen by adalimumab

References

• Abass, M.A., et al., 2017. Effect of orally administered zinc oxide nanoparticles on albino rat thymus and spleen. IUBMB Life, 69 (7), 528–539.
   PubMed Web of Science ®Google Scholar
• Akgun, Y., et al., 2019. Efficacy of adalimumab therapy in experimental rat sclerosing encapsulated peritonitis model. Croatian Medical Journal, 60 (5), 431–438.
   PubMed Web of Science ®Google Scholar
• Alqarni, A., and Zeidler, M., 2020. How does methotrexate work? Biochemical Society Transactions, 48 (2), 559–567.
   PubMed Web of Science ®Google Scholar
• Arifin, W.N., and Zahiruddin, W.M., 2017. Sample size calculation in animal studies using resource equation approach. Malaysian Journal of Medical Sciences, 24 (5), 101–105.
   PubMed Web of Science ®Google Scholar
• Audouin, J., et al., 2003. Myeloid sarcoma: clinical and morphologic criteria useful for diagnosis. International Journal of Surgical Pathology, 11 (4), 271–282.
   PubMed Web of Science ®Google Scholar
• Barnett, J.B., and Brundage, K.M., 2010. Evaluating macrophages in immunotoxicity testing. In: Immunotoxicity Testing, 598, 57–94.
   Google Scholar
• Bedoui, Y., et al., 2019. Methotrexate an old drug with new tricks. International Journal of Molecular Sciences, 20 (20), 5023.
   PubMed Web of Science ®Google Scholar
• Calleja, S., et al., 2012. Adalimumab specifically induces CD3(+) CD4(+) CD25(high) Foxp3(+) CD127(-) T-regulatory cells and decreases vascular endothelial growth factor plasma levels in refractory immuno-mediated uveitis: a non-randomized pilot intervention study. Eye, 26 (3), 468–477.
   PubMed Web of Science ®Google Scholar
• Campbell, J.M., et al., 2016. Methotrexate-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses. Cancer Chemotherapy and Pharmacology, 78 (1), 27–39.
   PubMed Web of Science ®Google Scholar
• Chabner, B.A., and Roberts, T.G., 2005. Timeline: chemotherapy and the war on cancer. Nature Reviews. Cancer, 5 (1), 65–72.
   PubMed Web of Science ®Google Scholar
• Chadwick, L., et al., 2018. Review of biosimilar trials and data on etanercept in rheumatoid arthritis. Current Rheumatology Reports, 20 (12), 1–9.
   Web of Science ®Google Scholar
• Chan, E.S.L., and Cronstein, B.N., 2013. Mechanisms of action of methotrexate. Bulletin of the Hospital for Joint Diseases, 71 (Suppl 1), S5–S8.
   Google Scholar
• Charan, J., and Kantharia, N., 2013. How to calculate sample size in animal studies? Journal of Pharmacology & Pharmacotherapeutics, 4 (4), 303–306.
   PubMedGoogle Scholar
• Chistiakov, D.A., et al., 2017. CD68/macrosialin: not just a histochemical marker. Laboratory Investigation; a Journal of Technical Methods and Pathology, 97 (1), 4–13.
   PubMed Web of Science ®Google Scholar
• Rodgers, G.P., 2012. Clinical and research information on drug-induced liver injury. In: Monoclonal antibodies. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases.
   Google Scholar
• Cure, E., et al., 2014. Adalimumab ameliorates abdominal aorta cross clamping which induced liver injury in rats. BioMed Research International, 2014, 907915.
   PubMed Web of Science ®Google Scholar
• Durmaz, S., et al., 2020. TNF-alpha inhibitor adalimumab attenuates endotoxin induced cardiac damage in rats. Acta Cirurgica Brasileira, 35 (2), 1–8.
   PubMed Web of Science ®Google Scholar
• Elmore, S., 2007. Apoptosis: a review of programmed cell death. Toxicologic Pathology, 35 (4), 495–516.
   PubMed Web of Science ®Google Scholar
• Fraser, S.D., et al., 2016. Reduced expression of monocyte CD200R is associated with enhanced proinflammatory cytokine production in sarcoidosis. Scientific Reports, 6, 38689–38611.
   PubMed Web of Science ®Google Scholar
• Freeman-Narrod, M., and Narrod, S.A., 1977. Chronic toxicity of methotrexate in mice. Journal of the National Cancer Institute, 58 (3), 735–741.
   PubMedGoogle Scholar
• Gori, J.L., et al., 2013. In vivo protection of activated tyr22-dihydrofolate reductase gene-modified canine T lymphocytes from methotrexate. The Journal of Gene Medicine, 15 (6–7), 233–241.
   PubMed Web of Science ®Google Scholar
• Institue of Safe Medication Pratices. 2019. QuarterWatchTM (includes new data from Quarter 2, 2019) methotrexate errors, trends among addictive drugs, and underreporting of serious events [online]. Institue of Safe Medication Pratices. Available from: https://www.ismp.org/resources/quarterwatchtm-includes-new-data-quarter-2-2019-methotrexate-errors-trends-among#:∼:text = It was first approved in,561%2C000 to 1 million patients.
   Google Scholar
• Kanbe, K., Chiba, J., and Nakamura, A., 2011. Decrease of CD68 and MMP-3 expression in synovium by treatment of adalimumab for rheumatoid arthritis. International Journal of Rheumatic Diseases, 14 (3), 261–266.
   PubMed Web of Science ®Google Scholar
• Kaplan, S., and Türk, A., 2020. Adalimumab increases follicle reserve and follicle development in rat ovary: the effect of adalimumab on ovarian reserve. Cureus, 12 (10), 1–9.
   Web of Science ®Google Scholar
• Lanier, L.L., et al., 1987. The gamma T-cell antigen receptor. Journal of Clinical Immunology, 7 (6), 429–440.
   PubMed Web of Science ®Google Scholar
• Lester, R.S., 1951. Methotrexate. Clinics in Dermatology, 7 (3), 128–135.
   Google Scholar
• Marble, D.J., Gordon, K.B., and Nickoloff, B.J., 2007. Targeting TNFalpha rapidly reduces density of dendritic cells and macrophages in psoriatic plaques with restoration of epidermal keratinocyte differentiation. Journal of Dermatological Science, 48 (2), 87–101.
   PubMed Web of Science ®Google Scholar
• Mease, P.J., 2007. Adalimumab in the treatment of arthritis. Therapeutics and Clinical Risk Management, 3 (1), 133–148.
   PubMedGoogle Scholar
• Mehrzadi, S., et al., 2018. Hepatoprotective effect of berberine against methotrexate induced liver toxicity in rats. Biomedicine & Pharmacotherapy, 97, 233–239.
   PubMed Web of Science ®Google Scholar
• Mercantepe, T., et al., 2018. Protective effects of tumor necrosis factor alpha inhibitors on methotrexate-induced pancreatic toxicity. Advances in Clinical and Experimental Medicine, 27 (6), 715–720.
   PubMed Web of Science ®Google Scholar
• Mercantepe, T., Tümkaya, L., and Mercantepe, F., 2018. Effects of infliximab against methotrexate toxicity in splenic tissue via the regulation of CD3, CD68, and C200R in rats. Cells Tissues Organs, 206 (6), 308–316.
   PubMed Web of Science ®Google Scholar
• Mercantepe, T., et al., 2016. Protective effects of estrogen and bortezomib in kidney tissue of post-menopausal rats: an ultrastructural study. Renal Failure, 38 (7), 1129–1135.
   PubMed Web of Science ®Google Scholar
• Nikiphorou, E., et al., 2014. Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort. Clinical Rheumatology, 33 (5), 609–614.
   PubMed Web of Science ®Google Scholar
• Norooznezhad, F., et al., 2020. Curcumin: hopeful treatment of hemophilic arthropathy via inhibition of inflammation and angiogenesis. Expert Review of Hematology, 13 (1), 5–11.
   PubMed Web of Science ®Google Scholar
• Osuji, N., et al., 2005. Histopathology of the spleen in T-cell large granular lymphocyte leukemia and T-cell prolymphocytic leukemia: a comparative review. The American Journal of Surgical Pathology, 29 (7), 935–941.
   PubMed Web of Science ®Google Scholar
• Preston, S., et al., 1997. Binds to a ligand on macrophages. European Journal of Immunology, 27 (8), 1911–1918.
   PubMed Web of Science ®Google Scholar
• Rjiba-Touati, K., et al., 2018. Recombinant human erythropoietin prevents etoposide- and methotrexate-induced toxicity in kidney and liver tissues via the regulation of oxidative damage and genotoxicity in Wistar rats. Human & Experimental Toxicology, 37 (8), 848–858.
   PubMed Web of Science ®Google Scholar
• Rondon, F., et al., 2011. Methotrexate-induced pulmonary toxicity in psoriatic arthritis (PsA): case presentation and literature review. Clinical Rheumatology, 30 (10), 1379–1384.
   PubMed Web of Science ®Google Scholar
• Rygiel, T.P., and Meyaard, L., 2012. CD200R signaling in tumor tolerance and inflammation: a tricky balance. Current Opinion in Immunology, 24 (2), 233–238.
   PubMed Web of Science ®Google Scholar
• Scheinfeld, N., 2005. Adalimumab: a review of side effects. Expert Opinion on Drug Safety, 4 (4), 637–641.
   PubMedGoogle Scholar
• Schnabel, A., et al., 1996. Long-term tolerability of methotrexate at doses exceeding 15 mg per week in rheumatoid arthritis. Rheumatology International, 15 (5), 195–200.
   PubMed Web of Science ®Google Scholar
• Spurlock, C.F., et al., 2012. Methotrexate increases expression of cell cycle checkpoint genes via JNK activation. Arthritis and Rheumatism, 64 (6), 1780–1789.
   PubMed Web of Science ®Google Scholar
• Suzuki, T., Tada, M., and Ishii-Watabe, A., 2020. Development of anti-drug monoclonal antibody panels against adalimumab and infliximab. Biologicals, 63 (August), 39–47.
   PubMed Web of Science ®Google Scholar
• Van Der Zee, H.H., et al., 2012. Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study. The British Journal of Dermatology, 166 (2), 298–305.
   PubMed Web of Science ®Google Scholar
• Wang, W., Zhou, H., and Liu, L., 2018. Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review. European Journal of Medicinal Chemistry, 158, 502–516.
   PubMed Web of Science ®Google Scholar
• Wessels, J.A.M., Huizinga, T.W.J., and Guchelaar, H.J., 2008. Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. Rheumatology, 47 (3), 249–255.
   PubMed Web of Science ®Google Scholar
• Zachariae, H., 1990. Methotrexate side-effects. British Journal of Dermatology, 122 (s36), 127–133.
   PubMed Web of Science ®Google Scholar
• Zeller, J.M., and Gudewicz, P.W., 1984. Functional resistance of inflammatory macrophages to methotrexate in vitro. Journal of Leukocyte Biology, 35 (5), 475–487.
   PubMed Web of Science ®Google Scholar